New ideas on the pathophysiology and treatment of lung disease

Thorax

Volumn 53, Issue 3, 1998, Pages 200-203

  Rogers, D F ^a   Laurent, G J ^b  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Airway inflammation; Asthma; Gene therapy; Lung disease; Pulmonary fibrosis; Review; Science Matters

Indexed keywords

CYTOKINE ANTIBODY; DECORIN; GLUCOCORTICOID; LIPOCORTIN 1; NITRIC OXIDE SYNTHASE INHIBITOR; PHOSPHODIESTERASE INHIBITOR; SECRETORY LEUKOCYTE PROTEINASE INHIBITOR; SURFACTANT; TACHYKININ RECEPTOR ANTAGONIST; TRANSMEMBRANE CONDUCTANCE REGULATOR;

ALPHA 1 ANTITRYPSIN DEFICIENCY; ARTICLE; ASTHMA; CYSTIC FIBROSIS; GENE THERAPY; HUMAN; INHALATIONAL DRUG ADMINISTRATION; LUNG DISEASE; LUNG FIBROSIS; LUNG LAVAGE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RESPIRATORY DISTRESS SYNDROME;

EID: 0031918120     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.53.3.200     Document Type: Article

References (21)

1. Middleton PG, Alton EWFW. Gene therapy for cystic fibrosis: which postman, which box? Thorax 1998;53:197-9.
2. Sallenave J-M, Porteous DJ, Haslett C. Gene therapy for lung inflammatory diseases: not so far away? Thorax 1997; 52:742-4.
3. Singh AD, Sanderson CJ. Anti-interleukin 5 strategies as a potential treatment for asthma. Thorax 1997;52:483-5.
4. Barnes PJ. NO or no NO in asthma? Thorax 1996;51:218-20.
5. Spina D. Airway sensory nerves: a burning issue in asthma? Thorax 1996;51:335-7.
6. Rogers DF. Scorpion venoms: taking the sting out of lung disease. Thorax 1996;51:546-8.
7. Dent G, Giembycz MA. Phosphodiesterase inhibitors: Lily the pink's medicinal compound for asthma? Thorax 1996;51:647-9.
8. Smith SF. Lipocortin 1: glucocorticoids caught in the act. Thorax 1996;51:1057-9.
9. Symon FA, Wardlaw AJ. Selecuns and their counter receptors: a bitter sweet attraction. Thorax 1996;51:1155-7.
10. Page CP. Proteoglycans: the 'Teflon' of the airways? Thorax 1997;52:924-5.
11. Erjefält JS, Persson CGA. Airway epithelial repair: breath-takingly quick and multipotentially pathogenic. Thorax 1997;52:1010-2.
12. Nicholas TE, Doyle IR, Bersten AD. Surfactant replacement therapy in ARDS: white knight or noise in the system. Thorax 1997;52:195-7.
13. Pabst R, Tschernig T. Lymphocyte dynamics: caution in interpreting BAL numbers. Thorax 1997;52:1078-80.
14. 1-proteinase inhibitor to combat pulmonary inflammation. Thorax 1996;51:1273-4.
15. Tomee JFC, Koëter GH, Kauffman HF. Secretory leukoprotease inhibitor: a native antimicrobial protein presenting a new therapeutic option? Thorax 1998,53:114-6.
16. Adnot S, Raffestin B. Pulmonary hypertension: NO therapy? Thorax 1996;51:762-4.
17. Scott PH, Peacock AJ. Cell signalling in pulmonary vascular cells: do not shoot the messengerl Thorax 1996;51:864-6.
18. Lympany PA, duBois RM. Diffuse lung disease: product of genetic susceptibility and environmental encounters. Thorax 1997;52:92-4.
19. Coker RK, Laurent GJ. Anticytokine approaches in pulmonary fibrosis: bringing factors into focus. Thorax 1997;52: 294-6.
20. Spurzem JR. Function at the junction: dynamic interactions between lung cells and extracellular matrix. Thorax 1996;51:956-8.
21. Persson CGA. In vivo veritas: the continuing importance of discoveries in complex biosystems. Thorax 1996;51:441-3.